According to IQVIA, the European market for Buprenorphine-based opioid dependency treatments in 2023 surpassed USD 355 million annually
The TGA approval marks a pivotal step in Rusan Pharma’s expansion into the Australian market
The centre features a cutting-edge climatic chamber for stability testing and spectrophotometry to ensure that products meet the most stringent manufacturing and testing standards
CPHI & PMEC India Expo 2024 to bring over 50,000 industry professionals and 2,000 exhibitors under one roof
ActivShield technology is a portable, novel sterilization modality that does not require conventional infrastructure
Sigachi's entry into the coatings market is strategically timed to capitalize on the industry's growth potential
This marks the first regulatory approval worldwide for nasally-delivered epinephrine
The acquisition of Healint aligns with Aptar Digital Health’s strategy to broaden its portfolio in neurology and strengthen its global footprint for digital health deployment
New facility is part of Aptar Pharma’s global expansion program
Construction will begin this year with the new capacity anticipated by 2025
Subscribe To Our Newsletter & Stay Updated
